GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (NYSE:COR) » Definitions » E10

Cencora (Cencora) E10 : $0.00 (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Cencora E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cencora's adjusted earnings per share data for the three months ended in Mar. 2024 was $2.090. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Cencora's average E10 Growth Rate was 33.10% per year. During the past 3 years, the average E10 Growth Rate was 34.80% per year. During the past 5 years, the average E10 Growth Rate was -0.50% per year. During the past 10 years, the average E10 Growth Rate was 3.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Cencora was 34.80% per year. The lowest was -16.60% per year. And the median was 13.40% per year.

As of today (2024-05-03), Cencora's current stock price is $224.74. Cencora's E10 for the quarter that ended in Mar. 2024 was $0.00. Cencora's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Cencora was 85.54. The lowest was 22.59. And the median was 42.36.


Cencora E10 Historical Data

The historical data trend for Cencora's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora E10 Chart

Cencora Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.17 1.27 1.79 2.40 3.11

Cencora Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.77 2.94 3.11 3.38 -

Competitive Comparison of Cencora's E10

For the Medical Distribution subindustry, Cencora's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cencora's Shiller PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cencora's Shiller PE Ratio falls into.



Cencora E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cencora's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.09/129.4194*129.4194
=2.090

Current CPI (Mar. 2024) = 129.4194.

Cencora Quarterly Data

per share eps CPI Adj_EPS
201406 -0.060 100.560 -0.077
201409 0.290 100.428 0.374
201412 -0.910 99.070 -1.189
201503 -2.330 99.621 -3.027
201506 0.890 100.684 1.144
201509 1.560 100.392 2.011
201512 1.450 99.792 1.880
201603 2.680 100.470 3.452
201606 1.550 101.688 1.973
201609 0.620 101.861 0.788
201612 1.110 101.863 1.410
201703 1.860 102.862 2.340
201706 0.230 103.349 0.288
201709 -1.350 104.136 -1.678
201712 3.900 104.011 4.853
201803 1.290 105.290 1.586
201806 1.250 106.317 1.522
201809 1.090 106.507 1.324
201812 1.840 105.998 2.247
201903 0.130 107.251 0.157
201906 1.430 108.070 1.713
201909 0.630 108.329 0.753
201912 0.900 108.420 1.074
202003 4.640 108.902 5.514
202006 1.410 108.767 1.678
202009 -23.740 109.815 -27.978
202012 1.810 109.897 2.132
202103 2.100 111.754 2.432
202106 1.400 114.631 1.581
202109 2.080 115.734 2.326
202112 2.130 117.630 2.343
202203 2.590 121.301 2.763
202206 1.920 125.017 1.988
202209 1.400 125.227 1.447
202212 2.330 125.222 2.408
202303 2.130 127.348 2.165
202306 2.350 128.729 2.363
202309 1.720 129.860 1.714
202312 2.980 129.419 2.980
202403 2.090 129.419 2.090

Add all the adjusted EPS together and divide 10 will get our e10.


Cencora  (NYSE:COR) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Cencora was 85.54. The lowest was 22.59. And the median was 42.36.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cencora E10 Related Terms

Thank you for viewing the detailed overview of Cencora's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Cencora (Cencora) Business Description

Traded in Other Exchanges
Address
1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Executives
Leslie E Donato officer: EVP & Chief Strategy Officer 227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Elizabeth S Campbell officer: Executive Vice President 1 WEST FIRST AVENUE, CONSHOHOCKEN PA 19428
Steven H Collis officer: President & CEO 1300 MORRIS DRIVE, SUITE 100, CHESTERBROOK PA 19087
Lazarus Krikorian officer: Senior Vice President 1300 MORRIS DRIVE, CHESTERBROOK PA 19087
Silvana Battaglia officer: Executive Vice President 227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Walgreens Boots Alliance, Inc. 10 percent owner 108 WILMOT ROAD, DEERFIELD IL 60015
Gina Clark officer: Executive Vice President 1300 MORRIS DRIVE, CHESTERBROOK PA 19087
Werner Baumann director 1 WEST FIRST AVENUE, CONSHOHOCKEN PA 19428
Lauren M Tyler director C/O ALLEGHANY CORPORATION, 1411 BROADWAY, 34TH FLOOR, NEW YORK NY 10018
Robert P. Mauch officer: Executive Vice President 1300 MORRIS DRIVE, CHESTERBROOK PA 19087
Redonda Miller director 303 WYMAN STREET, SUITE 300, WALTHAM MA 02451
Lorence H. Kim director C/O SERES HEALTH, INC., 161 FIRST STREET, CAMBRIDGE MA 02472
Walgreens Boots Alliance Holdings Llc 10 percent owner 108 WILMOT ROAD, DEERFIELD IL 60015
Lon R Greenberg director 460 NORTH GULPH ROAD, KING OF PRUSSIA PA 19406
John G. Chou officer: Executive Vice President 1300 MORRIS DRIVE, CHESTERBROOK PA 19087